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Abstract
Melanocortin signalling is mediated by binding to a family of G protein-coupled receptors that 
positively couple to adenylyl cyclase. Tetrapod species have five melanocortin (MC1-MC5) 
receptors. The number of receptors varies in fish, zebrafish, for example, having six melanocortin 
receptors, with two copies of the melanocortin MC5 receptor, while pufferfish have 4 receptors with 
no melanocortin MC3 receptor and one copy of melanocortin MC5 receptor. Fish genomes also 
exhibit orthologue genes for agouti-signalling protein (ASP) and -related protein (AGRP). AGRP 
expression is confined to a small area in the hypothalamus but ASP is expressed in the skin. Fish 
melanocortin MC2 receptor is specific for ACTH and requires the cooperation of accessory proteins 
(MRAP) to reach functional expression. The four other melanocortin MC receptors distinctively 
bind MSHs. The interaction of α-MSH and melanocortin MC1 receptor plays a key point in the 
control of the pigmentation and mutations of melanocortin MC1 receptor are responsible for reduced 
melanization. Both melanocortin MC4 and MC5 receptor are expressed in the hypothalamus, and 
central melanocortin MC4 receptor expression is thought to regulate the energy balance through the 
modulation of feeding behaviour. In addition, the peripheral melanocortin system also regulates 
lipid metabolism by acting at hepatic melanocortin MC2 and MC5 receptors. Both sea bass 
melanocortin MC1 and MC4 receptors are constitutively expressed in vitro and both ASP and AGRP 
work as inverse agonists but only after inhibition of the phosphodiesterase system. Accordingly, the 
overexpression of AGRP and ASP transgenes promotes obesity and reduces melanization in 
zebrafish, respectively. 
Keywords: Melanocortin-stimulating hormone (MSH); Proopiomelanocortin (POMC); Agouti-
signalling protein (ASIP); Agouti-related protein (AGRP); Melanocortin Receptor; Melanocortin 
receptor accessory protein (MRAP); Food Intake; Pigmentation; Stress
2
1. Introduction
Proopiomelanocortin (POMC) gene encodes a complex protein precursor that belongs to the 
opioid/orphanin gene family, which also includes proenkephalin, prodynorphin and proorphanin. 
This opioid/orphanin system was mainly formed by the two genome duplication rounds (2R) and 
probably a local duplication event during vertebrate evolution (Sundström et al., 2010). Tetrapod 
POMC precursor comprises three main domains: the N-terminal pro-γ-melanocyte stimulating 
hormone (MSH), the central adrenocorticotropic hormone (ACTH) and the C-terminal β-lipotropin. 
Each domain contains one MSH peptide delineated by a core sequence HFRW: γ-MSH in pro-γ-
MSH, α-MSH as N-terminal sequence of ACTH and β-MSH in β-lipotropin domain. The last 
domain further includes the C-terminal β-endorphin opioid peptide (Nakanishi et al., 1979).  The 
three-domain structure has also been reported in invertebrate species, suggesting that this 
organization represents a plesiomorphic character, although classical melanocortin receptors have 
been never reported in invertebrates (Stefano et al., 1993). The number of MSH domains varies in 
fish, depending on the taxonomic class. Ray-finned fish exhibit substitutions in the γ-MSH core 
(basal groups) or deletion (teleost fish). Lobe finned fish, including lungfish and coelacanth, 
inherited the three-domain ancestral condition but cartilaginous fish exhibit an additional δ-domain 
located between α- and β-MSH. An independent duplication event in agnathans coupled to 
specialization resulted in two genes, POC and POM, showing ACTH and MSHs domains, 
respectively (Takahashi and Kawauchi, 2006).  Avian and mammalian species have a single copy of 
the POMC gene but the genome of teleost antecessor doubled once more (3R) resulting in an 
expansion of the receptor/peptide systems. This event, together with particular tetraploidization 
events (e.g. salmonids), have resulted in additional copies of POMC in the genome of teleost fish. 
Sequencing projects have led to the conclusion that teleost fish, including zebrafish (Danio rerio), 
medaka (Oryzias latipes), three-spined stickleback (Gasterosteus aculeatus) and the puffefishes 
(Takifugu rubripes and  Tetraodon nigroviridis) exhibit two POMC (POMCa or α and POMCb or 
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β) paralogue genes (González-Nunez et al., 2003; Sundström et al., 2010). In addition, three 
different forms (a1, a2 and b) have been reported in barfin flounder (Verasper moseri; Takahashi et 
al., 2005). Studies in zebrafish suggest a subfunctionalization of the ancestral POMC sharing 
functions with the new paralogue gene in teleost fish (de Souza et al., 2005)
Tetrapod POMC is mainly produced in the vertebrate pituitary and its posttranslational processing 
occurs in a tissue-specific manner. The proteolytic cleavage of POMC by prohormone convertase 1 
(PC1) generates ACTH and β-lipotropin (β-LPH ) in the corticotrophs of the anterior pituitary, 
whereas cleavage by PC1 and PC2 produces α-MSH and β-endorphin in the melanotrophs of the 
pars intermedia (Castro and Morrison 1997).  As in other vertebrate species, fish POMC is mainly 
expressed in the pituitary gland. Two pituitary cell types produce melanocortin precursor. 
Corticotropes or ACTH-producing cells are localized in the rostral pars distalis, whereas 
melanotropes or MSH-producing cells are localized within the pars intermedia which is heavily 
innervated from the neurohypophysis to form the neurointermediate lobe in teleost fish (Cerdá-
Reverter and Canosa, 2009). The number of POMC cells is notably smaller within the rostral pars 
distalis than pars intermedia, which reflects the preferential isolation of α-MSH, β-MSH and β-
endorphin from the whole pituitary extracts (Takahashi and Kawauchi, 2006). Recent studies have 
demonstrated the differential processing of POMC in the pituitary of teleost fish (Takahashi et al., 
2006). Therefore, N-terminal POMC (equivalent to γ-MSH domain of tetrapods), des-acetyl α- 
MSH, α- MSH, CLIP (corticotropin-like intermediate peptide), N-β-LPH, β-MSH and N-acetyl-β-
endorphin has been isolated from the pars intermedia. This processing pathway in the pars 
intermedia is similar to that reported in mammalian species (Castro and Morrison, 1997). In the 
rostral pars distalis, N-POMC and ACTH have been isolated, as have des-acetyl α-MSH, CLIP and 
β-MSH. This suggests that, as in the mammalian system, ACTH is also produced within the pars 
distalis although this peptide may be further cleaved to des-acetyl α- MSH and CLIP, suggesting 
that corticotropes of the rostral pars distalis lack a MSH-acetylating system (Takahashi et al., 
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2008). 
In mammalian species, POMC is also centrally produced and mainly processed to α-MSH and β-
endorphin (Castro and Morrison, 1997). In rodents, two discrete groups of neurons in the 
hypothalamus (arcuate nucleus) and the medulla (nucleus of the tractus solitarius) also produce 
POMC (Bangol et al., 1999). POMC mRNA expression within the mediobasal hypothalamus has 
been conserved throughout vertebrate evolution, as POMC transcripts have been detected in 
hypothalamic neuronal systems of amphibians (Tuinhof et al., 1998), birds (Gerets  et al., 2000). 
Our experiments in goldfish have demonstrated that POMC is also expressed within the whole 
extension rostro-caudal extension of the lateral tuberal nucleus , which is thought to be the 
teleostean homologue of the arcuate nucleus (Cerdá-Reverter et al., 2003a). However, no POMC 
expression within the vagal lobe, the teleostean nucleus of the tractus solitarius, has been reported 
in any teleost species. Unfortunately, no information about POMC processing within the central 
nervous system is available.  
Melanocortin exerts its physiological role by binding to a family of specific G protein-coupled 
receptors that positively couple to adenylyl cyclase. Tetrapod species have five melanocortin (MC1-
MC5) receptors. In mammalian systems, melanocortin MC2 receptor is specific for ACTH. The four 
other MC receptors bind to MSHs, with melanocortin MC1 and MC3 receptors exhibiting the 
highest affinity for α-MSH and γ-MSH respectively (reviewed by Schiöth et al., 2005). Again, the 
number of receptors diverges in teleost fish. Zebrafish has six MC receptors, with two copies of the 
melanocortin MC5 receptor, while pufferfish have only 4 receptors with no melanocortin MC3 
receptor and only one copy of melanocortin MC5 receptor (Logan et al., 2003). Interestingly, 
perciform fish genome, the youngest teleost fish, lacks melanocortin MC3 receptor and γ-MSH 
domain in the POMC gene, suggesting co-evolution of the peptide/receptor system. 
Atypically, melanocortin signalling is not exclusively regulated by binding of endogenous agonists, 
as naturally occurring antagonists, agouti-signalling protein (ASP) and agouti-related protein 
(AGRP), compete with melanocortin peptides by binding to MC receptors.  ASP is a potent 
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melanocortin antagonist at melanocortin MC1 and MC4 receptors and relatively weak at 
melanocortin MC3 receptor. In mice, ASP is exclusively produced within the hair follicle and it 
locally regulates the production of pigment in follicular melanocytes by antagonizing the effects of 
α-MSH on melanocortin MC1 receptor. In contrast, AGRP is mainly produced within the 
hypothalamic arcuate nucleus and the adrenal gland and it strongly inhibits melanocortin signaling 
at melanocortin MC3 and MC4 receptors, but is not active at melanocortin MC1 receptor (Cone, 
2006). 
Several studies have demonstrated that mammalian ASP and AGRP work as inverse agonists at 
melanocortin MC4 receptor which is constitutively activated (Nijenhuis et al., 2001; Chai et al., 
2003). Therefore, melanocortin MC4 receptor signals in the absence of agonist binding. AGRP or 
ASP reduces constitutive melanocortin MC4 receptor signaling in a dose-dependent manner. The 
presence of melanocortin endogenous antagonist including AGRP and ASP in fish was first 
demonstrated in goldfish (Cerdá-Reverter and Peter, 2003, Cerdá-Reverter et al., 2005) and later in 
several teleost species (Song et al., 2003; Kurokawa et al., 2006; Murashita et al., 2009). Once 
again, paralogue genes for both ASIPs (ASIP1 and ASIP2) and AGRPs (AGRP1 and AGRP2) have 
been demonstrated in teleost (Kurokawa et al., 2006; Murashita et al., 2009). In goldfish, zebrafish 
and salmon, AGRP1 is expressed in several peripheral tissues, including skin, but in the central 
nervous system it is solely expressed within the lateral tuberal nucleus where POMC is also 
produced (Cerdá-Reverter et al., 2003 Forlano and Cone, 2008). In contrast, AGRP2 is only 
expressed in the pineal gland of the zebrafish but quantitative PCR (qPCR) studies in salmon have 
demonstrated wider AGRP2 expression at the periphery (Murashita et al., 2009). Unlike in the 
mammalian system, AGRP works as an inverse agonist and competitive antagonist at both sea bass 
melanocortin MC1 and MC4 receptors. ASIP is also widely expressed in the periphery despite a 
certain degree of central expression. In the periphery, ASIP is mainly expressed in the skin, where it 
is supposed to participate in the acquisition of the adult pigment pattern (Cerdá-Reverter et al., 
2005)   
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2. Melanocortins and food intake
Studies by Northern blot in goldfish (Cerdá-Reverter et al., 2003a), whole-mount in situ 
hybridization in zebrafish (Song et al., 2003) and qPCR in sea bass have demonstrated that POMC 
hypothalamic neurons cannot respond to progressive fasting that induces a severe reduction in 
weight (Sánchez et al., 2009a). Similar results have also been obtained in mammalian species. 
Therefore, POMC mRNA remain unchanged in chronically food-restricted sheep suffering about 
40% total body-weight loss (Henry et al., 2001) and long-term alterations in adiposity do not affect 
hypothalamic POMC expression in ovarectomized ewes that have lost about 30% total body weight 
(Henry et al., 2000). However, intracerebroventricular injections of melanocortin agonist, NDP-
MSH ([Nle4, D-Phe7] α-MSH), or  MTII (Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2), inhibit food 
intake in goldfish (Cerdá-Reverter et al., 2003a,b) and rainbow trout (Schjolden et al., 2009) in a 
dose dependent way. Accordingly, intracerebroventricular administration of HS024 (cyclo Ac-Cys-
Nle-Arg-His-D-Nal-Arg-Trp-Gly-Cys-NH2), in fed goldfish increased food intake four hours after 
treatment (Cerdá-Reverter et al., 2003b). Similar results were obtained in rainbow trout when using 
and SHU9119 (Ac-Nle-cyclo(Asp-His-D-2-Nal-Arg-Trp-Lys)-NH2), although the former had a 
more pronounced effect on food intake (Schjolden et al., 2009). These results suggest that the 
melanocortin system may be involved in the control of food intake of fish , although the lack of 
hypothalamic response to fasting leads to reservations concerning how the system is regulated. In 
the absence of a POMC hypothalamic response, the system can be regulated at three different levels 
at least: i) differential processing of POMC precursor after progressive fasting. Of note is the fact 
that the intracerebroventricular administration of β-endorphin, which is encoded at the C-terminal 
end of POMC, has been shown to stimulate appetite in the goldfish (De Pedro et al., 1995). Because 
of the contrasting actions of POMC peptides on food intake, the effects of nutritional status might 
manifest themselves at posttranscriptional levels by the differential regulation of the prohormone 
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convertases involved in goldfish POMC processing. In food-restricted goldfish with enhanced 
feeding drive, POMC cleavage may be directed towards the production of β-endorphin, whereas a 
positive energy balance may preferentially drive POMC processing to production of the food-intake 
inhibitor α-MSH. However, no experiments in fish have tested this hypothesis. ii) Adjustment in the 
number of central melanocortin receptors. The system could also be regulated by alteration of the 
receptor density in areas controlling food intake. Therefore, during fasting, the availability of 
receptors could be reduced, thus decreasing sensitivity to endogenous melanocortin peptides or 
constitutive signalling. Experiments in barfin flounder (Verasper mosari) and sea bass have 
demonstrated that progressive fasting does not modify melanocortin MC4 receptor mRNA 
expression levels in the hypothalamus (Kobayashi et al., 2008; Sánchez et al., 2009a) but no 
experiments have been carried out to evaluate the availability of the receptor at the plasma 
membrane iii) Counter regulation of receptor activity by the central melanocortin antagonists or 
inverse agonists. It is plausible that the activity of the receptor is basically regulated by the action of 
an inverse agonist, whereas proper agonists only work under specific physiological conditions. 
Experiments in goldfish (Cerdá-Reverter and Peter 2003) and zebrafish (Song et al., 2003) 
demonstrated that hypothalamic AGRP expression is dramatically increased during fasting at the 
same time intervals in which POMC expression remains constant. Our pharmacological 
experiments in goldfish and sea bass melanocortin receptors have demonstrated that zebrafish 
AGRP (83-127) is a potent competitive antagonist at sea bass melanocortin MC4 receptor (Sánchez 
et al., 2009a) but not at sea bass melanocortin MC5 receptor (Sánchez et al., 2009b). The C-terminal 
fragment of the zebrafish AGRP can also work as an inverse agonist, inhibiting both basal and 
forskolin-induced melanocortin MC4 receptor activity (Sánchez et al., 2009a; Sánchez et al., 2010). 
Suggestively, sea bass melanocortin MC4 receptor constitutive activity and/or AGRP inverse 
agonism, but not competitive antagonism, depends on inhibition of the intracellular 
phosphodiesterase system when the receptor is overexpressed in human embryonic kidney (HEK)-
293 cells. This suggests that both AGRP agonism and antagonism in the sea bass melanocortin MC4 
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receptor system are mediated through different intracellular signalling pathways with differential 
sensitivities to phosphodiesterase inhibitors. To the best of our knowledge, such phosphodiesterase 
dependence has been only studied in the sea bass melanocortin MC1 and MC4 receptors and this 
opens new targets for investigation of melanocortin-induced metabolic syndrome. 
Both HS024 and SHU9119 have been demonstrated to work as functional competitive antagonists 
at sea bass melanocortin MC4 receptor (Cerdá-Reverter et al., 2003b; Sánchez et al., 2009a; 
Sánchez et al, 2010). However, both compounds are potent agonists in goldfish melanocortin MC5 
receptor (Cerdá-Reverter et al., 2003c) and sea bass melanocortin MC5 receptor (Sánchez et al., 
2009b), suggesting that the central melanocortin effects on food intake are mediated via 
melanocortin MC4 receptor. In situ hybridization studies in goldfish (Cerdá-Reverter et al., 2003b) 
and sea bass (Sánchez et al., 2009a) have demonstrated that this receptor is profusely expressed 
within the CNS. In fact, sea bass melanocortin MC4 receptor expression is basically restricted to the 
CNS, while goldfish melanocortin MC4 receptor is also expressed in the peripheral tissues. Sea bass 
receptor transcripts are restricted to the telencephalon, preoptic area, ventral thalamus, tuberal and 
lobular hypothalamus, optic tectum and rombencephalon. The distribution of the receptor in 
goldfish brain is similar to that reported in sea bass, with transcripts within the rostral 
telencephalon, preoptic area and tuberal hypothalamus. Experiments in zebrafish (Forlano and 
Cone, 2007) and seabass (Ríos, Agulleiro, Leal, Cerdá-Reverter, unpublished results) suggest that 
melanocortin MC4 receptor distribution is consistent with the localization of MSH/AGRP 
immunoreactive terminals. In the zebrafish brain, AGRP terminals overlap the denser MSH 
innervation but both AGRP and MSH neurons also independently project into several areas. The 
highest innervation is found within the rostral and magnocellular preoptic area and caudal tuberal 
hypothalamus where we have described profuse expression of the sea bass melanocortin MC4 
receptor. The phenotype of the neurons expressing melanocortin MC4 receptor is unknown and 
deserves further investigation in the future but it is known that MSH terminals lie in close 
apposition to corticotrophin-releasing hormone-producing neurons in the posterior preoptic area of 
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the goldfish (Matsuda et al., 2008).  The preoptic and hypothalamic regions vary greatly among 
vertebrates. As described above, the lateral tuberal nucleus is thought to be the teleostean 
homologue of the mammalian arcuate nucleus, while the parvo- and magnocellular neurons of the 
preoptic nucleus seem to be homologues of the mammalian supraoptic and paraventricular nuclei, 
all of them pivotal points in the control of the energy balance in mammalian species (Berthoud, 
2002). Neuronal pathways involved in the control of food intake in fish are not well known. 
However, the tuberal hypothalamus, lateral torus and the inferior hypothalamic lobe have been 
suggested as being involved in the integration of the viscero-sensory information and elaboration of 
coordinated responses modifying the energy balance in fish (Rink and Wulliman, 2002). 
In summary, the results obtained in several fish species suggest that the melanocortin system may 
induce an inhibitory tone on food intake via constitutive activation of the central melanocortin MC4 
receptor. This constitutive tone is mainly regulated by the binding of AGRP within the tuberal 
hypothalamus and preoptic area. Agonist binding would increase melanocortinic tone under 
particular physiological conditions. In support of this hypothesis, it has been reported that the 
overexpression of AGRP in zebrafish results in increased linear growth and total body weight. 
Transgenic AGRP fish also exhibit visceral adipocyte hypetrtrophia and increased total triglyceride 
levels suggesting that these fish are obese (Song and Cone, 2007). The absence of systemic α-MSH 
also results in hyperphagia and obesity in rainbow trout. Therefore, the “cobalt” phenotype, so-
named because of its “cobalt-blue” body colour, has been attributed to the absence of most of the 
pars intermedia of the pituitary, where α-MSH is synthesized. This variant of trout is hyperphagic 
and, typically, also has an enlarged liver and shows fat accumulation in the abdominal cavity, 
reflecting the absence of α-MSH-mediated lipolytic activity (Yada et al., 2002). This suggests that 
the melanocortin system plays a dual role in the control of the energy balance by activating 
peripheral lipolytic activity, thus enhancing energy expenditure, and through the central inhibition 
of food intake. Experiments in sea bass have demonstrated that MSH can stimulate hepatic lypolisis 
via sea bass melanocortin MC5 receptor (Sánchez et al., 2009b)
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3. Melanocortins and pigmentation
Although more than 100 loci have been identified as being involved in vertebrate pigmentation, the 
melanocortin system is consistently a key determinant of the pigment phenotype. In mammals, the 
colour pattern is determined by the distribution of two pigments, pheomelanin (red/yellow) and 
eumelanin (brown/black). Both pigments are synthesized from a common precursor, dopaquinone,   
in response to respectively low or high levels of tyrosinase, the rate-limiting enzyme in the 
synthesis of melanins. Two main loci are responsible for the pheomelanin/eumelanin synthesis rate 
in the melanocyte- extension and agouti. The melanocortin MC1 receptor fills up the locus 
extension (Robbins et al. 1993) and regulates the synthesis of melanin via activation of tyrosinase. 
Briefly, α-MSH activation of melanocortin MC1 receptor leads to increased intracellular levels of 
cAMP, which, in turn, lead to phosphorylation of the cAMP responsive-element-binding protein 
(CREB). CREB transcriptionally regulates several genes, including the transcription factor 
microphtalmia (MITF). MITF is pivotal in the expression of several pigment-synthesizing enzymes, 
including tyrosinase, and differentiation factors (Lin and Fisher, 2007).  Therefore, melanocortin 
MC1 receptor activation, results in high levels of tyrosinase, which leads to eumelanogenesis and, 
by extension, to dark (brown/black) pigmentation (Sakai et al., 1997). Accordingly, recessive 
yellow mice (e/e) which exhibit an almost yellow fur have been demonstrated to carry a frameshift 
mutation between the fourth and fifth tramsmenbrane domain of melanocortin MC1 receptor, while 
a sombre phenotype (Eso/Eso) that has almost entirely black fur exhibits a point mutation that confers 
constitutive activity to the melanocortin MC1 receptor (Robbins et al. 1993). 
Agouti-signalling protein fills up the agouti locus (Bultman et al., 1992). This paracrine factor is 
synthesized in the hair bulbs and is efficiently released to melanocytes and hair matrix cells to 
regulate melanin production (Matsunaga et al., 2000). Agouti-signalling protein binding to 
melanocortin MC1 receptor reduces the constitutive or α MSH-induced signalling, reducing MITF 
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expression and resulting in lower tyrosinase levels than in the presence of high levels of cystein 
switches eumelanogenesis to pheomelanogenesis and by extension darker to paler (yellow/red) 
colour patterns (Sakai et al., 1997; Aberdam et al., 1998). A high degree of polymorphism in the 
ASP (Miltenberger et al., 2002)  and epigenetic modifications (Cropley et al., 2006) result in a high 
variety of mutant phenotypes, ranging from all black (a/a) to a uniform yellow (Ay/a) hair coat. Non 
agouti (a/a) extreme phenotypes carrying inactivating mutations in ASP display black fur (Bultman 
et al., 1992). The unusual allele, Ay, consists of a large deletion in the non-coding regions that 
places ASP gene under the control of the Raly promoter, an ubiquitously expressed RNA binding 
protein. The associated phenotype is characterized by ubiquitous expression of AS gene, resulting in 
yellow fur, hyperphagia, hyperinsulinemia, increased linear growth, an increased propensity for 
developing tumors, premature infertility and maturity-onset obesity (Miller et al., 1993; Michaud et 
al., 1994). This metabolic syndrome is mediated by antagonizing α-MSH signalling at the central 
melanocortin MC4 receptor that arbitrates the negative effects of melanocortin peptides on the 
energy balance (Lu et al., 1994). The ectopic expression of ASP in the brain mimics the action of 
AGRP, a central antagonist that regulates the inhibitory tone imposed by melanocortins on food 
intake at melanocortin MC3 and MC4 receptors (Cone, 2006). The regional and temporal expression 
of different ASP isoforms, produced by the usage of alternative promoters, is responsible for the 
dorsal ventral pigment pattern in mouse but also for the subapical yellow banding in the agouti 
coloration (Vrieling et al., 1994). Agouti-signalling protein not only modifies the switch from 
eumelanogenesis to pheomelanogenesis but also inhibits the differentiation of neural crest 
precursors into melanocytes (Aberdam et al., 1998; Sviderskaya et al., 2001). Microarray analyses 
of in vitro cultured melan-a melanocytes have suggested that cell treatment with ASP reproduces 
dedifferentiation stages by reducing the number of melanogenic proteins and increasing cell 
migration (Le Pape et al., 2009). 
Typical fish colour patterns are obtained as a result of the combination of several types of 
chromatophores commonly found in the dermis. Pigment cells are divided into light-absorbing 
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(melanophores, xantophores, erythrophores and cyanophores) and light-reflecting (leucophores and 
iridophores) chromatophores. Fish melanophores are known to contain only eumelanins (black-
brown pigments), whereas xantophores and erytrophores contain carotenoids and/or pteridines, 
which contribute to reddish and yellowish components of skin coloration. Iridophores are 
commonly localized in whitish and silvery areas of the skin, predominantly on the belly surface. 
They contain crystalline platelets composed of purines, mainly guanine, responsible for the 
reflection of the light. The interaction of light with the patterned distribution of pigmented cells 
creates the colour pattern in fish (Fuji, 1993). A common morphological pattern in many non-
mammalian vertebrates is a sharp demarcation in the coloration between dorsal and ventral areas. In 
teleosts, this countershading is achieved by a patterned distribution of the pigment cells, with the 
light-absorbing and light reflecting chromatophores mostly distributed in the dorsal and ventral 
areas, respectively (Fuji, 1993). Early experiments in amphibian and fish species suggested that the 
dorsal-ventral pigment pattern is achieved through a putative diffusible melanization inhibition 
factor (MIF), mainly produced by cells in the ventral skin, which inhibits melanoblast 
differentiation and stimulates or supports iridophore proliferation in the ventrum (Fukuzawa and 
Ide, 1988, Bagnara and Fukuzawa, 1990, Zuasti et al., 1992; Zuasti, 2002). Amphibian MIF was 
reported to block stimulation of the melanization provoked by α-MSH in neural explants of 
Xenopus (Fukuzaga and Bagnara, 1989). Subsequently, amphibian MIF was also shown to block α-
MSH-induced tyrosine hydroxylase and dopa oxydase activity in mouse malignant melanocytes, 
both key enzymes in the melanogenic pathway (López-Contreas et al., 1996). Although MIF has 
been partially purified and MIF-antibodies have localized its expression in the ventral skin of 
leopard frog (Rana forreri), the molecular structure remains unidentified (Fukuzaga et al., 1995). 
Similar experiments in catfish demonstrated that conditioned medium from catfish ventral skin and 
semi-purified amphibian MIF inhibits melanoblast differentiation but stimulates or supports 
iridophore proliferation (Zuasti, 2002). 
Recent studies have demonstrated that the melanocortin system is also a key player in the 
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establishment of the adult pigment pattern in fish. Frameshift mutations introducing a premature 
stop codon in melanocortin MC1 receptor or inactivating mutations in blind Mexican cave tetra 
(Astyanax mexicanus) are responsible for a decrease in the number of melanophores and in the 
melanin content. This phenotype was recapitulated by melanocortin MC1 receptor morpholino 
knockdown experiments in zebrafish (Gross et al., 2009). Our experiments in sea bass have 
demonstrated that sea bass melanocortin MC1 receptor is constitutively activated and expressed in 
both dorsal and ventral skin (Sánchez et al., 2010), suggesting that the ligand-independent activity 
of the receptor may be responsible for melanization in fish. If melanocortin MC1 receptor is 
constitutively activated and expressed in both dorsal and ventral surfaces, it would be difficult for 
fish to take on a dorsal ventral colour pattern.  Therefore, the melanocortin MC1 receptor function is 
probably inhibited in the ventrum to help establish the pigment pattern. This model goes along with 
the presence of non-diffusible MIFs in the ventral area but not in the dorsal region (see above). Our 
recent studies in goldfish strongly suggest that ASP fish orthologue is non-mammalian MIF. 
Experiments in goldfish (Cerdá-Reverter et al., 2005) and pufferfish (Kurokawa et al., 2006) 
showed that ASPis mainly expressed in the ventral skin with very low levels in the dorsal skin. The 
identity of ASP-expression cells is still unknown. Recombinant goldfish ASP interacts with the 
melanocortin system, working as a competitive antagonist and probably as an inverse agonist to 
decrease both the NDP-MSH-induced and constitutive intracellular accumulation of cAMP in 
pufferfish melanocortin MC1 receptor and goldfish melanocortin MC4 receptor expressing cell lines. 
Goldfish ASP also inhibits NDP-MSH-induced melanosome movements (Cerdá-Reverter et al., 
2005) and injection of capped goldfish ASP mRNA in the dorsal skin of flatfish, turbot 
(Scophthalmus maximus) and Senegalese sole (Solea senegalensis) dramatically inhibits 
melanization (Ceinos R, Guillot R, Rotllant P and Cerdá-Reverter JM, unpublished results). 
Therefore, our hypothesis is that melanocortin MC1 receptor constitutively drives melanization in 
fish skin but the inverse agonism of ASP in the ventral skin reduces melanocortin MC1 receptor 
activity, thus inhibiting both melanization and melanoblat differentiation but supporting iridophore 
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proliferation. This hypothesis could be extended not only to melanization since red/orange goldfish 
lacking melanocytes also display a dorsal-ventral pigment polarity. ASP is mainly expressed within 
the ventral skin of xanthic goldfish, suggesting that ASP inhibits the differentiation of light 
absorbing chromatophores (Cerdá-Reverter et al., 2005). We also hypothesized that the site of 
MITF expression inhibition lies downstream of ASP effects. Zebrafish exhibits two 
subfunctionalized copies of MITF (Lister et al., 2001). MITFa is coexpressed with MITFb in the 
retinal pigment epithelium but not in the neural crest melanoblast, where only MITFa is expressed. 
A single base mutation in the MITFa results in the almost complete absence of melanophores 
throughout embryonic and larval development, an absence that persists during adulthood in the 
nacre phenotype but pigmented retinal epithelium. 
In contrast to the absence of melanophores, nacre mutants show an approximate 40 % increase in 
the number of iridophores (Lister et al., 1999). MITF has also been reported to be sufficient to 
direct the differentiation of medaka embryonic stem-like cells into melanocytes (Béjar et al., 2002)
Nacre phenotype (inhibition of melanoblast differentiation and iridophore proliferation)  resembles 
those inferred properties of poikilotherm MIF that we have hypothesized to be ASP.  
Our experiments overexpressing ASP in transgenic zebrafish have demonstrated a dramatic 
reduction in the number of melanophores within the dark stripes and an increased number of 
iridophore, leading to a severe disruption of the stripe pattern that results into spotted “cheetahfish” 
(Guillot R, Ceinos R, Rotllant J and Cerdá-Reverter JM, unpublished results). 
The involvement of components of the melanocortin system other than melanocortin MC1 receptor 
and ASP in the colour pattern regulation in fish should be also considered. We have demonstrated 
that melanocortin MC5 receptor is highly expressed within the ventral skin but not in the dorsal skin 
of the sea bass (Sánchez et al., 2009b).  Similarly, goldfish melanocortin MC5 receptor is also 
expressed in the skin despite the lack of differentiation between dorsal and ventral areas (Cerdá-
Reverter et al., 2003b). Sea bass melanocortin MC4 receptor is not expressed in the skin (Sánchez et 
al 2009a) but a low level of sea bass melanocortin MC2 receptor expression was detected in both 
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dorsal and ventral areas (Agulleiro M, Sánchez E and Cerdá-Reverter JM, unpublished results). In 
contrast, goldfish melanocortin MC4 receptor is expressed within the dorsal skin but not in the 
ventral area (Cerdá-Reverter et al., 2003b). AGRP could be also involved in the regulation of the 
colour pattern in fish since expression levels in the dorsal skin were higher than those observed in 
the dorsal skin of the goldfish (Cerdá-Reverter and Peter, 2003). High levels of AGRP1 expression 
in the skin have been also reported in Atlantic salmon (Murashita et al., 2009) even though low 
levels were detected in pufferfish (Kurokawa et al., 2006) and sea bass (Agulleiro M, Sánchez E 
and Cerdá-Reverter JM unpublished results).   
4. Melanocortins and stress response
As in other vertebrates, activation of the hypothalamus-pituitary-interrenal axis plays an essential 
role in the stress response in fish. Following stressor exposure, the hypothalamic neurons release 
corticotrophin-releasing hormone (CRF) to the anterior pituitary (rostral pars distalis) where the 
corticotropes are located. The processing of POMC in the corticotrophs leads to the production of 
ACTH, which activates melanocortin MC2 receptor in the interregnal tissue (analogous to the 
adrenal cortex in tetrapods), which, in turn, controls cortisol synthesis. Cortisol, the main 
corticosteroid in fish, is released to the blood to regulate a wide array of systems in both stressed 
and non-stressed animals (Wendelaar Bonga, 1997; Flik et al., 2006; Alsop and Vijayan 2009). 
Studies on HPI development have demonstrated that the stress response is organized early in the 
ontogenetic process. Maternal POMC mRNA is already present in fertilized eggs but endogenous 
expression begins 18 hours postfertilization and POMC pituitary cells are visible by whole-mount 
in situ hybridization as early as 24 hours postfertilization  within the anterior domain (Hansen et al., 
2003).  These early corticotroph cells already respond to dexamethasone treatment (negative 
feeback) at 48h hours postfertilization but interrenal development, as assessed by the expression of 
key esteroideogenic enzymes, is only sensitive after 5 days post fertilization. Interrenal tissue 
development seems to be independent of pituitary development on the first two days post 
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fertilization. In fact, the expression of steroidogenic enzymes (22-28 hours postfertilization) 
precedes melanocortin MC2 receptor expression (32 hours postfertilization), and the expression 
pattern of the studied steroideogenic and chromafin genes is similar in mutants lacking pituitary 
cells (including corticotrophs). However, these mutants exhibit severe impairment of the interrenal 
function at 5 days postfertilization suggesting that proliferation and full functional differentiation of 
the interregnal organ depends on ACTH/ melanocortin MC2 receptor interaction (To et al., 2007).  
A cortisol stress response is obtained at 4 days postfertilization in zebrafish but early exposure to 
stressors seems to influence normal hypothalamus-pituitary-interrenal axis development; in 
particular, the magnitude of cortisol response to stressors is reduced during adulthood (Alsop and 
Vijayan, 2009). 
In adult rainbow trout, acute stressors rapidly elicit a significant increase in plasma ACTH (1 hour 
post-stress) and melanocortin MC2 receptor expression (4 hours post-stressor). This up-regulation of 
melanocortin MC2 receptor expression is clearly induced by the ACTH since in vitro incubation of 
interregnal slides with the hormone leads to an increase in the receptor expression. Using this in 
vitro system in rainbow trout, ACTH was able to induce an increase in cortisol synthesis that was 
not blocked by melanocortin MC4 receptor antagonist (SHU9119), but NDP-MSH was incapable of 
inducing cortisol release to the cell culture medium. This suggests that α-MSH is not involved in 
the cortisol response to stress (Aluru and Vijayan, 2008) despite reports that melanocortin MC5 
receptor is profusely expressed in the head kidney of the rainbow trout (Haitina et al., 2004). 
Similar results were also reported in carp even though α-MSH levels were increased after 1 and 7 
days of restraint stress. The superfusion of interrenal tissue with homogenate from the pars 
intermedia elicited an increase in cortisol release, suggesting the presence of unknown corticotrops 
in the above pituitary domain (Metz et al., 2005). In summary, it seems that, as in other vertebrates, 
melanocortin MC2 receptor is the main player in the cortisol response to stress.
The study of melanocortin MC2 receptor activation has been limited because of the lack of a readily 
transfectable heterologous expression system. Only adrenocortical-derived cell lines (Y6 or OS3), 
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from which endogenous melanocortin MC receptor expression is absent, have rendered appropriate 
data on melanocortin MC2 receptor pharmacology (Schimmer et al., 1995). Expression experiments 
in a range of non-adrenal cells suggested that melanocortin MC2 receptor cannot reach the plasma 
membrane and is retarded in the endoplasmic reticulum, thus compromising its functional 
expression. This justification suggested the presence of an accessory factor that works as an 
melanocortin MC2 receptor-specific transport system in the adrenocortical cells (Noon et al., 2002). 
One gene candidate that encodes for a small single transmembrane domain protein with high 
expression in the adrenal cortex was identified in humans, showing familial glucocorticoid 
deficiency (FGD). This syndrome is characterized by resistance to ACTH, i.e. high plasma ACTH 
levels but lacking adrenal glucocorticoids. The protein is known as melanocortin MC2 receptor 
accessory protein (MRAP). The alternative splicing of the last two exons gives rise to two isoforms 
that differ in the C-terminal region (MRAPα and MRAPβ ;  Metherell et al., 2005). 
Knockdown of endogenous mouse MRAP in Y1 adrenocortical cells, which express a functional 
endogenous melanocortin MC2 receptor, leads to insensitivity to ACTH, demonstrating that MRAP 
is essential for producing an ACTH responsive melanocortin MC2 receptor (Cooray et al., 2008). 
MRAP interacts with the melanocortin MC2 receptor to facilitate correct folding, and subsequent  
glycosylation and receptor cell surface expression (Metherell et al., 2005) but they are also essential 
for ACTH binding and ACTH-induced cAMP production (Sebag and Hinkle, 2009a; Roy et al., 
2007). Recent experiments have identified a second form of MRAP in the human genome called 
MRAP2. This protein shares the structural characteristics of MRAP but is expressed only in the 
human brain and adrenal gland. Similar to MRAP1, MRAP2 assists melanocortin MC2 receptor cell 
surface expression and allows the ACTH-induced cAMP production (Sebag and Hinkle, 2009a; 
Chan et al., 2009). Our preliminary experiments expressing sea bass melanocortin MC2 receptor in 
HEK-293 cells failed to generate an ACTH-stimulated cAMP increase. However, when human 
MRAPs were cotransfected, the sea bass melanocortin MC2 receptor was able to mediate ACTH-
induced cAMP production, suggesting the presence of a conserved melanocortin MC2 receptor 
18
trafficking system in non-mammalian vertebrates.             
In silico searches using available public databases rendered three different MRAPs in zebrafish, i.e. 
MRAP1, MRAP2a and MRAP2b. Subsequently, we identified orthologue sequences in several 
teleosts fish. MRAP1 is mainly expressed in the anterior kidney of the zebrafish presumably in the 
interregnal tissue but the cell type has not been identified. In contrast, both MRAP2a and MRAP2b 
expression was found in every tissue tested. Cell trafficking studies demonstrated that zebrafish 
melanocortin MC2 receptor cannot reach plasma membrane when overexpressed in HEK-293 cells. 
When zebrafish or human MRAP1 (Agulleiro MJ, Roy S, Gallo-Payet N and Cerdá-Reverter JM, 
unpublished results) was coexpressed together with zebrafish melanocortin MC2 receptor in the 
above cell system, both proteins were colocalized in the cell surface. However, when zebrafish 
melanocortin MC2 receptor was coexpressed with MRAP2a or MRAP2b, both receptor and accessory 
protein labelling fluorochromes were colocalized but never in the plasma membrane. Both zebrafish 
melanocortin MC2 receptor and MRAP2a were mainly found in the cytoplasm, while zebrafish 
melanocortin MC2 receptor and MRAP2b were colocalized in the cytoplasm and also in the nuclear 
membrane (Agulleiro et al., 2010). Interestingly, it has been reported that mouse melanocortin MC2 
receptor is complexed with nucleoporin 50 expressed in Y6 adrenal cells and translocated from the 
membrane to the nucleus after ACTH stimulation (Doufexis et al., 20007). Therefore, it is possible 
that MRAP2 may be involved in this novel signalling pathway. According to trafficking studies, 
zebrafish melanocortin MC2 receptor responds to ACTH stimulation only when co-expressed with 
zebrafish MRAP1 or human MRAP1, but not with zebrafish MRAP2a or MRAP2b, as seen from 
increases in the intracellular cAMP levels in HEK cells. The receptor did not became functional in 
the absence of MRAP1 but when MRAP2a or MRAP2b were coexpressed together with MRAP1 in 
cells stably expressing zebrafish melanocortin MC2 receptor, the magnitude of the response was 
increased. This suggests that MRAP1 cooperates with the MRAP2 subtypes to increase the ACTH 
response (Agulleiro et al., 2010). 
Developmental studies in zebrafish demonstrated that MRAP1 expression is exclusively detected by 
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whole-mount in situ hybridization in the interregnal tissue at 4 days post fertilization; however, 
studies revealing MRAP2a and MRAP2b expression consistently detected diffuse expression within 
the brain at 2 days post fertilization. After 2 days, pituitary corticotrops are already responsive to 
dexamethasome but ACTH-dependent interregnal tissue development was noted at 5 days post 
fertilization (see above), suggesting that interregnal MRAP1 expression could be a crucial point in 
ACTH-dependent interrenal tissue development (Agullerio MJ, Guillot R, Sanchez and Cerdá-
Reverter, unpublished results). Incipient studies on MRAP1 promoter revealed putative recognition 
sites for peroxisome proliferator-activated receptor (PPAR), estrogen receptor (ER) and 
glucocorticoid receptors (GR), which suggests that MRAP1 is not only an accessory protein but a 
key point in the regulation of ACTH-induced glucocorticoid synthesis or, by extension, in the stress 
response in vertebrates.   
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